SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection

Havervall S, Jernbom Falk A, Klingström J, Ng H, Greilert-Norin N, Gabrielsson L, Salomonsson AC, Isaksson E, Rudberg AS, Hellström C, Andersson E, Olofsson J, Skoglund L, Yousef J, Pin E, Christ W, Olausson M, Hedhammar M, Tegel H, Mangsbo S, Phillipson M, Månberg A, Hober S, Nilsson P, Thålin C

PLoS One 17 (1) e0262169 [2022-01-12; online 2022-01-12]

Category: Biochemistry

Category: Health

Funder: KAW/SciLifeLab

Funder: VR

Research Area: Biobanks for COVID-19 research

Research Area: Drug discovery and repurposing of drugs

Research Area: High-throughput and high-content serology

Research Area: Host cell systems biology and targets

Type: Journal article

PubMed 35020778

DOI 10.1371/journal.pone.0262169

Crossref 10.1371/journal.pone.0262169


Publications 7.1.2